三管反:对当前干预管理的审查
Maxwell Ambrosino1, Matthew Sangoi1, Nasser Monzer1
1Pennsylvania Hospital University of Pennsylvania Philadelphia PA USA.
Journal of the American Heart Association
|March 12, 2024
概括
三管吐管理正在发展. 新型透导管疗法为患者提供了更好的安全性和生活质量,超越了传统的利尿剂方法.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 三管吐 (TR) 是一种普遍且复杂的心脏疾病.
- 传统的治疗与利尿剂提供没有死亡率的好处.
- 由于过时的技术,历史上的手术干预结果很差.
研究的目的:
- 审查TR干预的临床,成像和血液动力学标准.
- 讨论TR的干预管理的不断变化的格局.
- 为突出TR的手术和透导管治疗的最新进展.
主要方法:
- 对TR患者临床发现的审查.
- 对TR评估的成像方式的分析.
- 对指导干预的血液动力学参数的评估.
- 评估新型跨导管边缘到边缘修复装置的结果.
主要成果:
- 跨导管边缘到边缘的修复显示出安全性和有效性的承诺.
- 这些新疗法可以显著减少三管吐.
- 干预管理改善了患者的生活质量.
结论:
- 现代的外科手术和透导管方法为TR提供了新的希望.
- 根据临床,成像和血液动力学数据进行仔细的患者选择至关重要.
- 三管修复方面的进展正在改变患者护理.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


